Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
<Research>BofAS Keeps Buy Rating on CHINA LIFE (02628.HK), Expects 1Q NBV to Grow 20-30%
Recommend 26 Positive 32 Negative 23 |
||||
|
||||
|
CHINA LIFE (02628.HK)'s 2025 net profit rose 44%YoY, BofA Securities issued a research report saying. In 4Q25, due to a significant QoQ decline in investment income and lower insurance service revenue, the Company recorded a net loss of RMB13.7 billion. The broker expected CHINA LIFE's 1Q26 new business value to grow by 20-30%. However, due to the Company's aggressive investment strategy, BofA Securities anticipated a YoY decline in net profit, but believed that short-term fluctuations in investment income should not affect its forecasts for the Company's long-term and normal investment returns. BofA Securities raised its 2026 earnings forecast for CHINA LIFE by 5%, but lowered its 2027 earnings forecast by 1%. The broker kept its target price/ rating for CHINA LIFE's H-shares at $33.1/ Buy. AASTOCKS Financial News Website: www.aastocks.com |
||||
Copied to Clipboard
 |
||||
